The Denver Channel |
Bristol-Myers immunotherapy combo promising in melanoma: study
Reuters (Reuters) - A combination of two Bristol-Myers Squibb drugs that help the immune system fight melanoma led to significantly greater tumor shrinkage than treatment with one of the medicines, according to a midstage study presented on Monday. Bristol-Myers: 2 cancer drugs beat 1 against melanoma Bristol-Myers Drug Combination Shows Promise Against Melanoma First Randomized Study Evaluating Opdivo (nivolumab)+Yervoy (ipilimumab ... |
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment